Marshall Wace North America’s AngioDynamics ANGO Stock Holding History

Marshall Wace North America’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-19,707	Closed	-$316K	–	1207
2019 Q4	$316K	Sell	19,707 -37,184	-65%	-$568K	﹤0.01%	888
2019 Q3	$1.05M	Sell	56,891 -23,839	-30%	-$466K	0.01%	681
2019 Q2	$1.59M	Buy	+80,730	New	+$1.64M	0.01%	623
2018 Q3	–	Sell	-39,391	Closed	-$876K	–	907
2018 Q2	$876K	Sell	39,391 -12,205	-24%	-$249K	﹤0.01%	963
2018 Q1	$890K	Sell	51,596 -231,161	-82%	-$3.86M	﹤0.01%	1028
2017 Q4	$4.7M	Sell	282,757 -208,263	-42%	-$3.55M	0.03%	596
2017 Q3	$8.35M	Buy	491,020 +70,555	+17%	+$1.19M	0.05%	419
2017 Q2	$6.73M	Buy	+420,465	New	+$6.65M	0.05%	410
2013 Q4	$258K	Buy	+15,025	New	+$231K	0.01%	617

Other funds holding ANGO

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Marshall Wace North America's ANGO Position: Q1 2020 in Review

Marshall Wace North America sold out of AngioDynamics (ANGO) in Q1 2020, closing a stake of 19,707 shares — an estimated $316K sold.

Marshall Wace North America first reported a position in ANGO in Q4 2013 and held it in 9 quarters. The position peaked at $8.35M in Q3 2017. 158 funds tracked by Wall St. Rank hold ANGO as of Q1 2020.

Marshall Wace North America reported no remaining AngioDynamics position as of Q1 2020 after selling out during the quarter.
Marshall Wace North America sold 19,707 AngioDynamics shares in Q1 2020, an estimated $316K.
Marshall Wace North America first reported a position in AngioDynamics in Q4 2013 and held it in 9 quarters.
Marshall Wace North America's AngioDynamics position peaked at $8.35M in Q3 2017.
158 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2020.

Based on Marshall Wace North America's 13F filing for Q1 2020, filed 15 May 2020.